Effects of miR-16 plus CA19-9 detections on pancreatic cancer diagnostic performance

Clinical Laboratory

Volumn 60, Issue 1, 2014, Pages 73-77

  Gao, Ling ^a   He, Song Bing ^a   Li, De Chun ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

CA19 9; Combination; Diagnostic performance; MiR 16; Pancreatic cancer

Indexed keywords

ADULT; CA-19-9 ANTIGEN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PANCREATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 84893934077     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.121210     Document Type: Article

References (24)

1. Grzesiak JJ, Vargas F, Bouvet M. Divalent cations modulate alpha2beta1 integrin-mediated malignancy in a novel 3-dimensional in vitro model of pancreatic cancer. Pancreas 2010;39:904-12.
2. Soreide K, Aagnes B, Moller B, Westgaard A, Bray F. Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965-2007. Scand J Gastroenterol 2010;45:82-92.
3. Talar-Wojnarowska R, Gasiorowska A, Olakowski M, Lekstan A, Lampe P, Malecka-Panas E. Clinical value of serum neopterin, tissue polypeptide-specific antigen and CA19-9 levels in differential diagnosis between pancreatic cancer and chronic pancreatitis. Pancreatology 2010;10:689-94.
4. Lee H, Choi HJ, Kang CS, Lee HJ, Lee WS, Park CS. Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma. Mod Pathol 2012;25:1508-15.
5. Muvva C, Tewari L, Aruna K, et al. In silico identification of miRNAs and their targets from the expressed sequence tags of Raphanus sativus. Bioinformation 2012;8:98-103.
6. Qiao-Ying Z, Cun-Yi Y, Qi-Bin M, Xiu-Ping L, Wen-Wen D, Hai N. Identification of wild soybean miRNAs and their target genes responsive to aluminum stress. BMC Plant Biol 2012;12:82.
7. Xi Y, Edwards JR, Ju J. Investigation of miRNA biology by bioinformatic tools and impact of miRNAs in colorectal cancer-regulatory relationship of c-Myc and p53 with miRNAs. Cancer Inform 2007;3:245-53.
8. Blasberg R. Imaging gene expression and endogenous molecular processes: molecular imaging. J Cereb Blood Flow Metab 2002;22:1157-64.
9. Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 2010;10:297-308.
10. Zhang YK, Zhu WY, He JY, et al. miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes. J Cancer Res Clin Oncol 2012;138:1641-50.
11. Waggott D, Chu K, Yin S, Wouters BG, Liu FF, Boutros PC. NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data. Bioinformatics 2012;28:1546-8.
12. Mostert B, Sieuwerts AM, Martens JW, Sleijfer S. Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients. Expert Rev Mol Diagn 2011;11:259-75.
13. Koscianska E, Baev V, Skreka K, et al. Prediction and preliminary validation of oncogene regulation by miRNAs. BMC Mol Biol 2007;8:79.
14. Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Res 2012;14:R77.
15. Porkka KP, Ogg EL, Saramaki OR, et al. The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers. Genes Chromosomes Cancer 2011;50:499-509.
16. Sampath D, Liu C, Vasan K, et al. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia. Blood 2012;119:1162-72.
17. Shen J, Wan R, Hu G, et al. miR-15b and miR-16 induce the apoptosis of rat activated pancreatic stellate cells by targeting Bcl-2 in vitro. Pancreatology 2012;12:91-9.
18. Ren Y, Gao J, Liu JQ, et al. Differential signature of fecal micro RNAs in patients with pancreatic cancer. Mol Med Report 2012;6:201-9.
19. Morikawa T, Kuchiba A, Liao X, et al. Tumor TP53 expression status, body mass index and prognosis in colorectal cancer. Int J Cancer 2012;131:1169-78.
20. Sort OF. MicroRNA changes in advanced radiotherapy techniques and its effect to secondary cancers. Med Hypotheses 2012;79:421-2.
21. Toscano-Garibay JD, Aquino-Jarquin G. Regulation exerted by miRNAs in the promoter and UTR sequences: MDR1/P-gp expression as a particular case. DNA Cell Biol 2012;31:1358-64.
22. Hufbauer M, Lazic D, Reinartz M, Akgul B, Pfister H, Weissenborn SJ. Skin tumor formation in human papillomavirus 8 transgenic mice is associated with a deregulation of oncogenic miRNAs and their tumor suppressive targets. J Dermatol Sci 2011;64:7-15.
23. Liu J, Gao J, Du Y, et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 2012;131:683-91.
24. Reid JF, Sokolova V, Zoni E, et al. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res 2012;10:504-15.